ProQR’s retinitis pigmentosa treatment gets orphan drug designation

November 21, 2019
QR-1123, a first-in-class investigational antisense oligonucleotide for the treatment of vision loss associated with autosomal dominant retinitis…

Meeting NewsVideo

VIDEO: Novel oral therapy drug safe, effective for wet AMD

November 21, 2019
SAN FRANCISCO —Twice daily dosing of oral AKST4290 over the course of 6 weeks improved visual acuity in patients with neovascular age-related…

Meeting NewsVideo

VIDEO: AI, deep learning rapidly evolving to real-world applications in diagnosing retinal disease

November 19, 2019
NEW YORK — At OSN New York 2019, Darius Moshfeghi, MD, discusses the progress being made around the world in research into artificial…

Meeting News

Patients with AMD can successfully self-operate OCT device at home

November 19, 2019
SAN FRANCISCO — Patients with age-related macular degeneration could successfully self-operate an optical coherence tomography device at home…

Home monitoring systems, longer-acting drugs should ease burden of retinal disease

Ocular Surgery News U.S. Edition, November 25, 2019
New longer-acting molecules and home monitoring will soon help relieve the increasing burden of age-related macular degeneration and diabetes-related…

Meeting News

Luminate shows potential in dry AMD

November 15, 2019
SAN FRANCISCO — Risuteganib showed potential for the treatment of intermediate dry age-related macular degeneration, according to study results…

Chocolate study leads October retina news

November 14, 2019
Retina-related news on Healio/OSN in October included an FDA approval, study results and meeting news coverage. Here are the top five most-read…

Meeting News

Test combining fundus, OCT imaging improves AMD diagnosis

November 13, 2019
SAN FRANCISCO — A screening strategy combining fundus and OCT imaging improved the accuracy of age-related macular degeneration classification…


BLOG: Gene therapy promising for treatment of neovascular AMD

November 12, 2019
This year’s American Academy of Ophthalmology meeting in San Francisco had significant data releases from pharmaceutical companies focused on…

Meeting NewsVideo

VIDEO: Gene therapy for wet AMD ‘on the horizon’

November 11, 2019
SAN FRANCISCO — In the OPTIC trial, patients with wet age-related macular degeneration who were treated with ADVM-022, an intravitreal gene…

Cedars-Sinai receives $10.5 million to study RP stem cell treatment

November 8, 2019
Cedars-Sinai researchers have received a $10.5 million grant from the California Institute for Regenerative Medicine to launch a clinical trial…

$17.2 million grant awarded to research Alzheimer’s connection with eye health

November 7, 2019
The National Institute on Aging has awarded a $17.2 million grant to University of Washington School of Medicine assistant professor of ophthalmology…

Meeting News

OpRegen subretinal transplantation appears well-tolerated in dry AMD

November 7, 2019
SAN FRANCISCO — OpRegen, a human embryonic stem cell-derived retinal pigment epithelial cell therapy transplanted subretinally, appeared…

Proper protection, treatment can reduce severity of sports eye injuries

November 6, 2019
On the court and in the field of play, the risk for sports-related eye injuries is prevalent. Knowing how to properly treat the injuries as well as…

In the Journals

Autologous neurosensory retinal transplant successful for refractory macular holes

November 4, 2019
Autologous neurosensory retinal transplant surgery proved successful in closing refractory macular holes and also improving vision in some cases. A…

Meta-analysis links RVO, cardiovascular risks

Ocular Surgery News U.S. Edition, November 10, 2019
The risk for a cardiovascular event, such as stroke or heart attack, was greater in patients with retinal vein occlusion than in those without…

Meeting NewsVideo

VIDEO: Effects of Iluvien reimplantation in patients with DME

November 2, 2019
SAN FRANCISCO — At the American Academy of Ophthalmology meeting, Matthew Manry, MD, discusses his poster presentation on the findings of…


BLOG: Why AMD fluid subtypes matter

October 31, 2019
It has been more than 10 years since the introduction of anti-VEGF therapy for neovascular age-related macular degeneration, and the number of…

Meeting NewsVideo

VIDEO: Treating DME globally

October 30, 2019
SAN FRANCISCO — At the American Academy of Ophthalmology meeting, Caesar K. Luo, MD, FACS, discusses global safety signals in the use of…

Meeting News

Ziv-aflibercept may be safe, less expensive alternative to other anti-VEGF treatments

October 30, 2019
SAN FRANCISCO — Ziv-aflibercept could be an effective and cost-reducing alternative to traditional anti-VEGF therapies in the treatment of…